The ISOBIOTICS Project, coordinated by Dr. C. Dugave at CEA is a European intersectorial Doctoral Network which aims at devising novel approaches for the isotopic labeling of biologic drugs such as peptides, proteins, oligonucleotides and analogs, with 2H/3H, 13C/14C and 18F and to train a cohort of young talented chemists from Feb 2023 to January 2027. The fellows (M/F/O) will prepare a PhD in 3 or 4 years (depending on the university of attachment). The project's Consortium recruits 10 + 1 Early-Stage Researchers (Graduate Students) as follows:
2 positions at CEA-Saclay (FR) granted by EU (Supervisors: G. Pieter & D. Audisio) in 3 years for 2H/3H and 13C/14C labeling
1 position at CEA-Orsay (FR) granted by EU (Supervisor: B. Kuhnast) in 3 years for 18F labeling
1 position at Ludwig Maximilians Universität (GE) granted by EU (Supervisor: T. Carell) in 3 years for 2H and 13C labeling
2 positions at SANOFI GmbH (GE) granted by EU (Supervisor: V. Derdau) in 3 years for 2H/3H and 13C/14C labeling
1 position at ASTRAZENECA-Stockholm (SE) granted by EU (Supervisor: M. Schou) in 4 years for 18F labeling
1 position at ASTRAZENECA-Mölndal (SE) granted by EU (Supervisor: C. Elmore) in 3 years for 13C/14C labeling
2 positions at CHEMPRECISE (PT) granted by EU (Supervisor: G. Bernardes) in 3 years for 18F labeling
1 position at the Rosalind Franklin Institute (UK) granted by UK (Supervisor: B. Davis) in 4 years for ingeneering of biologics
The applicants must have been awarded with a Master degree in Chemistry/Biochemistry or equivalent and must not have spent more than 12 months in the hosting country in the past 3 years. The selected candidates will get a 3 year contract (at minima) cosigned by the recruiting entity.
For more information, please look at the participants' websites and on specific offers in EURAXESS.
Please, directly contact the corresponding supervisor. All position must be filed by Jan 2024 at the latest. End of recruitment June 2023.
BenefitsThe fellows will be awarded with a PhD degree as follows:
3 CEA fellows: University Paris-Saclay (Thesis Director: G. Pieters, D. Audisio, B. Kunahst, FR)
1 Ludwig Maximilians Univ.: Ludwig Maximilians Univ.(Thesis Director: T. Carell, GE)
Sanofi: 1 at Ludwig Maximilians Univ.(Thesis Director: T. Carell, GE) and 1 Univ. Rostock (Thesis Director: M. Beller, GE)
AstraZeneca: 1 at Karolinska Institutet (Thesis Director: M. Schou, SE) and 1 at Aarhus Univ. (Thesis Director: T. Skrydstrup, DK)
ChemPrecise: 2 at Faculdade de Farmacia da Universidade de Lisboa (Thesis Director:R Moreiras, PT)
Eligibility criteriaThe applicants must have been awarded with a Master degree in Chemistry/Biochemistry or equivalent and must not have spent more than 12 months in the hosting country in the past 3 years. The selected candidates will get a 3 year contract (at minima) cosigned by the recruiting entity.
Fluent English speaking and writing is mandatory (Please note that there is English language qualifying assessment at Karolinska).
Selection processFor more information, please look at the participants' websites and on specific offers in EURAXESS.
Please, directly contact the corresponding supervisor. Send a CV and a letter/email of motivation.
All position must be filed by Jan 2024 at the latest. End of recruitment June 2023.
Offer RequirementsChemistry: Master Degree or equivalent
Biological sciences: Master Degree or equivalent
ENGLISH: Excellent
Skills/QualificationsThe applicants must have been awarded with a Master degree in Chemistry/Biochemistry or equivalent and must not have spent more than 12 months in the hosting country in the past 3 years. The selected candidates will get a 3 year contract (at minima) cosigned by the recruiting entity.
Fluent English speaking and writing is mandatory.
Specific RequirementsApplicants must be passionated by bio-organic chemistry and organic synthesis for Chemical Biology (chemistry of biological macromolecules) and associated sciences (biochemistry, molecular biology, click-chemistry and chemical catalysis).
Contact Information